共 14 条
Effectiveness of sotalol treatment in symptomatic Brugada syndrome
被引:15
作者:
Glatter, KA
Wang, Q
Keating, M
Chen, SH
Chiamvimonvat, N
Scheinman, MM
机构:
[1] Univ Calif Davis, Dept Cardiol ACC, Sacramento, CA 95817 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Case Western Reserve Univ, Ctr Cardiovasc Genet, Dept Mol Cardiol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin Fdn, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Cleveland Clin Coll Med, Cleveland, OH 44106 USA
[6] Boston Childrens Hosp, Boston, MA USA
关键词:
D O I:
10.1016/j.amjcard.2004.02.023
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms. Genetic testing revealed that he carried a Brugada syndrome sodium channel SCN5A mutation (4189delT). This finding suggests that sotalol may be of therapeutic benefit in such patients. (C) 2004,by Excerpta Medica, Inc.
引用
收藏
页码:1320 / 1322
页数:3
相关论文